Jacqueline E. Zoberi

Tri-APBI: Single-Institution Phase I/II Prospective Clinical Trial of 3-Fraction Accelerated Partial Breast Irradiation for Stage 0-I Breast Cancer

William R Kennedy, S.C. Raju-Salicki, Maria A Thomas, Jacqueline E. Zoberi et autres

PURPOSE: This study aims to report safety, feasibility, toxicity, cosmetic, and quality-of-life (QOL) outcomes of a single-institutional prospective phase I/II clinical trial evaluating a novel 3-fraction accelerated partial breast irradiation (Tri-APBI) regimen. METHODS AND MATERIALS: From August 2018 to March 2021, 75 …

us (code pays fourni par la source)

Long-Term Outcomes of Multimodality Accelerated Partial Breast Irradiation for Ductal Carcinoma In Situ

S.C. Raju-Salicki, H.B. Stowe, Alden D'Souza, Yi Huang et autres

Purpose: To report long-term institutional outcomes for ductal carcinoma in situ treated with accelerated partial breast irradiation (APBI) using multiple modalities as a part of breast-conserving therapy. Methods and Materials: From January 2001 to April 2019, 240 patients with stage 0 breast …

us (code pays fourni par la source)

Quality and Safety Considerations for Radiopharmaceutical Therapy in the Radiation Oncology Environment: An ASTRO Safety White Paper

Jacqueline E. Zoberi, Y Charara, Freddy E. Escorcia, Robert F. Hobbs et autres

us (code pays fourni par la source)

Enhancing safety: Multi‐institutional FMEA and FTA on 177Lu$^{177}{\rm Lu}$‐based radio‐pharmaceutical therapy

Siju C George, Santiago Aguirre, Nichole M. Maughan, Ranjini Tolakanahalli et autres

Abstract Purpose This study investigates potential failure modes and conducts failure mode and effects analysis (FMEA) and fault tree analysis (FTA) on the administration of DOTATATE (LUTATHERA) and PSMA‐617 (PLUVICTO). The quality management (QM) process in radiopharmaceutical therapies (RPTs) requires collaboration between …

us, in (code pays fourni par la source)

GSOR06 Presentation Time: 11:55 AM

Alice Silberstein, Michael R. Waters, Phillip Wall, Jacqueline E. Zoberi et autres

us (code pays fourni par la source)

PO0120

Jorge H Ramírez, H. Michael Gach, Julie Rolfingsmeier, Phillip Wall et autres

us (code pays fourni par la source)

Thursday, July 11, 20245:00 PM - 6:00 PMMSOR1 Presentation Time: 5:00 PM

Aaron Silvus, Ethan Memming, Thomas R. Mazur, Liyun Chen et autres

us (code pays fourni par la source)

PHSOR05 Presentation Time: 9:20 AM

Ha Yeon Kim, Hania Al‐Hallaq, Juergen Meyer, Angelia Landers et autres

us (code pays fourni par la source)

PHSOR06 Presentation Time: 9:25 AM

Sharbacha S. Edward, Justin Mikell, José Garcia-Ramirez, Michael B. Altman et autres

us (code pays fourni par la source)

Three discipline collaborative radiation therapy (3DCRT) special debate: Systemic radiotherapy using targeted isotopes is the best hope for advancing curative radiation therapy

Bridget F. Koontz, Marianne Koritzinsky, Jacqueline E. Zoberi, Stephen L. Brown et autres

Radiation oncology is a highly multidisciplinary medical specialty, drawing significantly from three scientific disciplines-medicine, physics, and biology.As a result, discussion of controversies or changes in practice within radiation oncology involves input from all three disciplines.We have adopted a similar "team-science" approach to …

us, ca (code pays fourni par la source)

Single-Institution Phase 1/2 Prospective Trial Evaluating Three-Fraction Partial Breast Irradiation: Four Year Outcomes Including Quantitative Cosmesis and Patient-Reported Outcomes

Sandra Raju, Mustafa Mahmood, Jacqueline E. Zoberi, Monica A. Thomas et autres

Distribution of Responsibility across the HDR Brachytherapy Team: Results of a Nationwide Survey

Jacqueline E. Zoberi, John P. Meyer, Hania Al‐Hallaq, A. L. Landers et autres

us (code pays fourni par la source)